Browse all 648 ETFs by category, no search needed
Global 183
US market 62
Country 92
Core UCITS 15
Sector 103
Style & factor 111
Theme 45
Dividend 37
Global X Genomics & Biotechnology ETF (GNOM)
Look-through valuation · Sector · Expense ratio 0.50 % · ISIN US37954Y4347
Price history (since 2019)
Monthly close since 2019. Price shows performance, the valuation verdict is in the look-through above.
Top holdings
Fair value and quality per position come from the same valuation as our stock pages. Showing the 25 largest of 50 disclosed positions. "n/a" means the position is not (yet) in our stock universe and does not enter the average.
The 10 most cheaply valued ETFs
Measured against the look-through fair value of the holdings (sufficiently covered funds only). Green means below fair value, red above. Not financial advice.
- 1 C003 Amundi Index Solutions - Amundi DivDAX I UCITS ETF EUR Distributing +22.2 % below FV
- 2 FCFY First Trust S&P 500 Diversified Free Cash Flow ETF +17.9 % below FV
- 3 ITB iShares U.S. Home Construction ETF +9.8 % below FV
- 4 SHRY First Trust Bloomberg Shareholder Yield ETF +2.2 % below FV
- 5 COWZ Pacer US Cash Cows 100 ETF -0.3 % above FV
- 6 C001 Amundi Core DAX UCITS ETF Dist -2.4 % above FV
- 7 XLC Communication Services Select Sector SPDR® Fund -4.2 % above FV
- 8 EWP iShares MSCI Spain ETF -4.8 % above FV
- 9 FTXO First Trust Nasdaq Bank ETF -6.0 % above FV
- 10 KRE SPDR® S&P Regional Banking ETF -8.9 % above FV
How the look-through works
An ETF has no fair value of its own like a single stock. We build it bottom up: every holding has a fair value and a quality score on our pages. Weighted by portfolio share, that gives Global X Genomics & Biotechnology ETF an average of how cheap or expensive its companies currently sit versus fair value, and how high their average quality is.
As of: Jul 28, 2026
No investment advice, no buy or sell recommendation. The look-through is a computed summary of public fundamentals and is no substitute for your own research.